Table 1 Baseline characteristics (mean/SD) of the two groups of endometriotic patients having GnRH agonist or Dienogest as a pretreatment before ART

Age (years)^a

35.6 ± 3.5

36.1 ± 2.7

0.24

BMI (Kg/m2)^a

22.5 ± 1.6

22.3 ± 1.9

0.18

Duration of subfertility^a

6.6 ± 1.5

7.2 ± 1.7

0.1

Previous ART (%) ^b

20/67 (29.85%)

17/67 (25.37%)

0.56

Previous live birth (%) ^b

10/67 (14.93%)

10/67 (14.93%)

1

 Male

25 (37.31%)

27 (40.3%)

–

 Anovulation

27 (40.3%)

30 (44.78%)

 Tubal

32 (47.76%)

32 (47.76%)

 uterine

23 (34.33%)

30 (44.78%)

 Minimal

5/67 (7.46%)

8/67 (11.94%)

0.69

 Mild

13/67 (19.4%)

12/67 (17.91%)

 Moderate

27/67 (40.3%)

22/67 (32.84%)

 Severe

22/67 (32.84%)

25/67 (37.31%)

FSH (IU/L)^a

5.4 ± 1.7

4.3 ± 1.8

0.22

AMH (ng/ml)^a

3.5 ± 1.3

2.8 ± 1.8

0.07

AFC^a

12 ± 3.2

11.8 ± 2.3

0.08